SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

NuGene International Inc (OTCBB:NUGN), a leading developer, marketer and manufacturer of advanced hair and skin care lines announces the findings of the second Princeton consumer research study. As per the reports, it sees 40.6% reduction in fine line and wrinkles. The study was conducted right after the firm came up with its own Universal Cream in the last month.

Objectives of Second Princeton Consumer Research Study:

The Princeton Consumer Research study was designed with an objective to evaluate the efficiency of the Eye Serum and Universal Serum of the company with relation to the untreated skin. The Princeton Consumer Research came up with a bi-lateral, single-blinded facial study on 28 different male and female subjects who’re 35 year or older and had aged skin. The prime objective of this experiment was to evaluate the anti-aging efficiency of NuGene’s Eye Serum and Universal Serum over a period of 8 weeks.

The active site of the company revealed a significant improvement from baseline within the first four weeks of the treatment in all the subjective and objective assessments.

Conclusion of The Study:

On the basis of the research study that lasted for a few weeks, the research team found out that Eye Serum and Universal Serum applied side witnessed 40.65% reduction in wrinkles and fine lines. Apart from this, they also found out that the moisture level of the skin was 20.39% at the end of the 8-week-treatment.

Management Call:

The senior management of the comapny is excited to see these results. According to Dr. M. Saeed Kharazmi, Chairman, NuGene International Inc (OTCBB:NUGN), this third party study supports the marketing claims that the firms has made. These results comply with firm’s visions and ensure that wrinkles and fine lines can be treated. It’s a proud moment for the company and the entire management team to share these results with the stakeholders.